PUMA BIOTECHNOLOGY, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2010 | — | — | $0 |
| FY2011 | $1.0M | $55.4M | $53.4M |
| FY2012 | $22.8M | $151.7M | $137.4M |
| FY2013 | $20.4M | $104.4M | $43.0M |
| FY2014 | $45.7M | $162.8M | $38.5M |
| FY2015 | $33.8M | $239.8M | $31.6M |
| FY2016 | $43.0M | $252.8M | $194.5M |
| FY2017 | $112.2M | $165.5M | $81.7M |
| FY2018 | $224.8M | $259.1M | $108.4M |
| FY2019 | $217.4M | $234.9M | $60.0M |
| FY2020 | $250.2M | $244.2M | $85.3M |
| FY2021 | $229.0M | $226.6M | $63.1M |
| FY2022 | $200.5M | $222.1M | $76.2M |
| FY2023 | $177.1M | $230.5M | $84.6M |
| FY2024 | $121.2M | $213.3M | $69.2M |
| FY2025 | $86.0M | $216.3M | $29.6M |